Jun 22, 2004
Guidant Corporation to Provide Update on Drug Eluting Stent Program

Webcast Scheduled for July 1 at 4:30 PM EDT

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its previously announced conference call on Thursday, July 1, 2004, at 4:30 PM EDT. During the call, the company will provide an update on its drug eluting stent program.

Participating on the conference call will be Guido J. Neels, chief operating officer, Guidant Corporation and Dana G. Mead, Jr., president, Vascular Intervention, Guidant Corporation.

A live webcast of Guidant''s conference call will be accessible through the company''s website at www.guidant.com/webcast. The webcast will be archived for future on-demand replay.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 12,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life''s most threatening medical conditions. For more information visit www.guidant.com.

System requirements for the webcast include Internet Explorer 5.0 (or higher) or Netscape Navigator 4.0 (or higher). Users also should have the most recent version of Windows Media Player, which can be downloaded for free at http://www.microsoft.com/windows/windowsmedia/en/download/. Users may experience varying levels of performance based on their connection speed, system capabilities and presence of a corporate firewall. To ensure a connection, users should go to the program five to 15 minutes before its start.